The FDA is now warning of new dangers associated with Ketek, the first antibiotic of the ketolide class. Primarily used in treatment for chronic bronchitis, acute bacterial sinusitis and varying levels types of pneumonia, Ketek has been linked to rare cases of serious liver injury and liver failure. At least four confirmed deaths have been linked to the drug. To address these issues, the manufacturer, Sanofi Aventis, has now revised its warning label.
@thumbnail.jpg "M. Brandon Smith")
A partner with Childers, Schlueter & Smith, LLC,, Brandon Smith has devoted his practice to pharmaceutical litigation, mass torts, products liability and serious personal injury. A frequent guest speaker at legal seminars all over the country—Brandon is focused on helping injured victims nationwide, however possible. Named a SuperLawyer again in 2019, he has also been called out as one of 10 Best Attorneys For Georgia by the American Institute Of Personal Injury Attorneys and a Top 100 Lawyer in Georgia by the National Trial Lawyers in 2019.
Comments for this article are closed.